Results 161 to 170 of about 222,361 (282)
On Fusing Wireless Fingerprints with Pedestrian Dead Reckoning to Improve Indoor Localization Accuracy. [PDF]
Sensors (Basel)Fernando GC +4 more
europepmc +1 more source
An Improved Pedestrian Ttracking Method Based on Wi-Fi Fingerprinting and Pedestrian Dead Reckoning. [PDF]
Sensors (Basel), 2020 Feng B, Tang W, Guo G, Jia X.
europepmc +1 more source
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Accurate Localization Method Combining Optimized Hybrid Neural Networks for Geomagnetic Localization with Multi-Feature Dead Reckoning. [PDF]
Sensors (Basel)Yan S +5 more
europepmc +1 more source
Molecular Oncology, EarlyView.A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Design of a wireless assisted pedestrian dead reckoning system – the NavMote experience
, 2005 — In this paper, we combine inertial sensing and sensor network technology to create a pedestrian dead reckoning system. The core of the system is a lightweight sensor-andwireless-embedded device called NavMote that is carried by a pedestrian.
Panos J. Antsaklis +10 more
core
Grid-Based Bayesian Filtering Methods for Pedestrian Dead Reckoning Indoor Positioning Using Smartphones. [PDF]
Sensors (Basel), 2020 Opiela M, Galčík F.
europepmc +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
A Fail-Operational Control Architecture Approach and Dead-Reckoning Strategy in Case of Positioning Failures. [PDF]
Sensors (Basel), 2020 Matute-Peaspan JA +2 more
europepmc +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source